Biomedical subjects
V Vonka
Publications and source records attributed to V Vonka.
Penetration of nuclear inclusions into the cytoplasm in influenze-virus-infected cells.
Explore the source record for details and available documents.
Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence.
Explore the source record for details and available documents.
[Choice of antigen for preparation of the anti-human antilymphocyte serum (ALS)].
Explore the source record for details and available documents.
A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
Explore the source record for details and available documents.
Infections with herpesviruses in a closed infants' community.
Explore the source record for details and available documents.
Morphological changes in BHK-21 cells infected with S-N (H2N1) influenza virus.
Explore the source record for details and available documents.
Increased oncogenicity and synthesis of herpesvirus antigens in hamster cells exposed to herpes simplex type-2 virus.
Explore the source record for details and available documents.
Multiplicity reactivation in UV-irradiated herpes simplex type 1 virus.
Explore the source record for details and available documents.
Genetic interaction between two influenza A-WS virus mutants. 3. Capacity of WS-NWS recombinants to reproduce in various cell systems.
Explore the source record for details and available documents.
Increase of EB virus positive cells in cultured Burkitt lymphoma cells after short-time exposure to heat.
Explore the source record for details and available documents.
[Clinical reactivity and immunological activity of 2 subunit influenza vaccine in infants].
Explore the source record for details and available documents.
Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cells in infectious mononucleosis patients.
Explore the source record for details and available documents.
A modified immunofluorescence test for detecting EB virus antibody.
Explore the source record for details and available documents.
Increase of Epstein-Barr-virus-positive cells in EB3 cultures after treatment with cis-dichloro-diammine-platinum.
Explore the source record for details and available documents.
Influence of cis-dichlorodiammineplatinum (II) on growth of SV 40 virus in green monkey kidney cells.
Explore the source record for details and available documents.
Inactivation of papovavirus SV 40 by cis-dichlorodiammine platinum(II).
Explore the source record for details and available documents.
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.
In 1968 in Poland an extensive outbreak of poliomyelitis, caused by type 3 poliovirus, began about four months after small vaccine trials with the Leon 12a(1)b (Sabin) and USOL-D bac vaccine strains had been carried out. Because of the temporal association, and because the first cases appeared in the province in which the USOL-D vaccine trial was carried out, a detailed investigation of the strains isolated from cases in the epidemic was made in four laboratories in an attempt to determine whether they were related to the two vaccine strains or to a "wild" strain. All the studies were made under code. The rct marker was of no help in determining the relationship of the epidemic strains to the vaccine strains. The McBride test and the elution marker test clearly separated the Leon 12a(1)b strains from those from the cases, but were incapable of detecting whether the epidemic strains were related to the USOL-D bac strain or to wild type 3 strains. Thus the studies did not provide valid information on the origin of the epidemic.